Siblings Conference Papers/Meeting Abstract [41/48] Papers [0/1] Patents [0/11] Collection Statistics Item counts issued in 3 years:0(0.00%) Items With Fulltext:193(99.48%) Download counts of the item Download times greater than 0:193(100.00%) Download times greater than 100:193(100.00%) Total Bitstream Download Counts:122982(83.64%) Last Update: 2024-12-01 10:25 Top Upload Loading... Top Download Loading... Recent Submissions Identification of prognostic biomar... A novel NRF2/ARE inhibitor gossypol... Targeting lysosomal cysteine protea... c-MYC-directed NRF2 drives malignan... Ephrin A4-ephrin receptor A10 signa... Phase I dose-escalation study of SC... Germline susceptibility variants im... Index of cancer-associated fibrobla... The SMAC mimetic LCL161 is a direct... The tumor suppressor TGFBR3 blocks ...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 151-175 of 194. (8 Page(s) Totally) << < 1 2 3 4 5 6 7 8 > >> View [10|25|50] records per page

Date	Title	Relation
2007-10	A novel oral indoline-sulfonamide agent, N-[1-(4-Methoxy-benzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-Isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule	Journal of Pharmacology and Experimental Therapeutics. 2007 Oct;323(1):398-405.
2007-10	Human tissue kallikreins as prognostic biomarkers and as potential targets for anticancer therapy	Expert Opinion on Therapeutic Patents. 2007 Oct;17(10):1227-1240.
2007-09-06	4-and 5-aroylindoles as novel classes of potent antitubulin agents	Journal of Medicinal Chemistry. 2007 Sep;50(18):4548-4552.
2007-07-31	Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil	British Journal of Cancer. 2007 Jul;97(3):334-344.
2007-03-01	Mitochondria-mediated and p53-associated apoptosis induced in human cancer cells by a novel selenophene derivative, D-501036	Biochemical Pharmacology. 2007 Mar;73(5):610-619.
2007-02-26	Cytotoxic and novel skeleton compounds from the heartwood of Chamaecyparis obtusa var. formosana	Tetrahedron Letters. 2007 Feb;48(9):1567-1569.
2007-02-17	Lysosomal cysteine proteinase cathepsin S as a potential target for anti-cancer therapy	Journal of Cancer Molecules. 2007 Feb 17;3(1):5-14.
2007-01	D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation	Molecular Cancer Therapeutics. 2007 Jan;6(1):193-202.
2006-12	Statistical quality control process for traditional Chinese medicine	Journal of Biopharmaceutical Statistics. 2006 Dec;16(6):861-874.
2006-11-27	C-35 terpenoids from the bark of Calocedrus macrolepis var. formosana with activity against human cancer cell lines	Journal of Natural Products. 2006 Nov;69(11):1611-1613.
2006-11-16	7-aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents	Journal of Medicinal Chemistry. 2006 Nov;49(23):6656-6659.
2006-11	Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma	Cancer Chemotherapy and Pharmacology. 2006 Nov;58(5):654-664.
2006-10-19	2-amino and 2 '-aminocombretastatin derivatives as potent antimitotic agents	Journal of Medicinal Chemistry. 2006 Oct;49(21):6412-6415.
2006-10	Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents	ChemMedChem. 2006 Oct;1(10):1106-1118.
2006-09-25	Synthesis of new camptothecin analogues with the E-lactone ring replaced by alpha,beta-cyclohexenone	European Journal of Organic Chemistry. 2006 Sep(19):4490-4499.
2006-07-28	In vitro and in vivo studies of a novel potential anticancer agent of isochaihulactone on human lung cancer A549 cells	Biochemical Pharmacology. 2006 Jul;72(3):308-319.
2006-05	Antitubulin agents for the treatment of cancer - a medicinal chemistry update	Expert Opinion on Therapeutic Patents. 2006 May;16(5):647-691.
2006-05	Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer	Journal of Gastroenterology and Hepatology. 2006 May;21(5):874-879.
2006-03	Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer	Journal of Gastroenterology and Hepatology. 2006 Mar;21(3):531-536.
2005-12-01	Synthesis and antitumor activity of 5-(9-acridinylamino)anisidine derivatives	Bioorganic and Medicinal Chemistry. 2005 Dec;13(23):6513-6520.
2005-12	Pulmonary embolism after transcatheter arterial chemoembolization	European Journal of Cancer Care. 2005 Dec;14(5):440-442.
2005-09	Long-term complete remission of metastatic gastric cancer after weekly docetaxel, 24 h infusion of high-dose 5-FU/leucovorin and cisplatin	Journal of Gastroenterology and Hepatology. 2005 Sep;20(9):1470-1471.
2005-08-01	alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma	Alimentary Pharmacology and Therapeutics. 2005 Aug;22(3):217-226.
2005-06	Hepatocellular carcinoma associated with acquired von Willebrand disease and extreme thrombocytosis	Annals of Oncology. 2005 Jun;16(6):988-989.
2005-02	Cytotoxic triterpenes from the aerial roots of Ficus microcarpa	Phytochemistry. 2005 Feb;66(4):495-501.

Showing items 151-175 of 194. (8 Page(s) Totally) << < 1 2 3 4 5 6 7 8 > >> View [10|25|50] records per page